Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 115
Selected: 0
NCT IDTitle
NCT02786875Diet, Exercise and Vitamin D in Breast Cancer Recurrence
NCT05806151Prediction of True Oligo-metastatic Disease.
NCT07213557Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy
NCT05733793Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.
NCT05233982MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
NCT04893785A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
NCT01481545Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
NCT01005641ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
NCT02633189Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung Cancer
NCT00415779ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
NCT07269249Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer
NCT00401674MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
NCT05821556Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
NCT03874026Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
NCT01649674Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT01405573Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
NCT04310176Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer
NCT04893356Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
NCT06866093The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.
NCT06218511A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
NCT06880523STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
NCT04726228Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
NCT01593488Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
NCT07267780Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
NCT02784171Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
NCT06341764Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma
NCT00403429MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer
NCT07213570STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
NCT00660842Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT06509126Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
NCT01802749Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
NCT04317092Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
NCT03380858REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal Anastomosis
NCT03473379Development and Validation of a Tool for Patient-reported Assessment of Cancer-related Financial Toxicity in Italy
NCT01405586MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
NCT01755182Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors
NCT04416672Validation of the Italian Version of the PRO-CTCAE
NCT06884878Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)
NCT00331097ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
NCT00526643CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
NCT04123925Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study
NCT04071704Assessing Health-related Quality of Life in Sarcoma Patients
NCT00330746CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer
NCT00401492MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer
NCT04129255Octreotide LAR in the Induction of Immunologic Response in NENs Patients
NCT06032975PRO for Fighting FT in Ovarian Cancer
NCT06236464Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06894823Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
NCT06714357ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
NCT00385606Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC